Stephen Zale Fadem MD FACP, FASN

Chief Medical Officer Kidney Associates

6560 FanninSuite 1730Houston, TX 77030
Phone+1 713-795-5511

Dr. Fadem is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Fadem's full profile Already have an account?

Summary

Dr. Stephen Fadem is a nephrologist based in Houston, TX, with expertise in general nephrology, transplant nephrology, glomerular disease, dialysis, and hereditary kidney disease. He completed his medical education at the University of Oklahoma College of Medicine and pursued a nephrology fellowship at the University of Texas Health Science Center San Antonio. He is currently the Medical Director at DaVita Medical Center and Chief Medical Officer at Kidney Associates. Dr. Fadem has contributed to several publications related to nephrology, and he has experience in clinical trials concerning chronic kidney disease. He has received multiple CMS Meaningful Use certifications for his work.

Education & Training

University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Nephrology, 1976 - 1978
University of Texas Health Science Center at HoustonResidency, Internal Medicine, 1973 - 1976
University of Oklahoma College of MedicineClass of 1973

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

TX State Medical License 1974 - 2028
OK State Medical License 1974 - 2027
FL State Medical License 2012 - 2017
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Nephrology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Falcon EHR, Falcon, LLC, 2012, 2014-2017
CMS Meaningful Use Stage 2 Certification Greenway Intergy Meaningful Use Edition, Greenway Health, LLC, 2012, 2014-2017
CMS Meaningful Use Stage 1 Certification Falcon, Falcon, LLC, 2012, 2014-2017

Clinical Trials

Efficacy and Safety of Tolvaptan in Subjects With Chronic Kidney Disease Between Late Stage 2 to Early Stage 4 Due to Autosomal Dominant Polycystic Kidney Disease
COMPLETED
PHASE3
Safety Study of the Aethlon Hemopurifier
TERMINATED
NA

Publications & Presentations

PubMed

1 citations
The role of serum phosphate control in supporting transplant readiness in patients on dialysis.
Laura A Williams, Stephen Z Fadem
Current Medical Research and Opinion. 2025-09-01
The Positive Impact of Patient Education on Tenapanor Adherence in the OPTIMIZE Study.
Rory C Pace, David P Tietjen, David M Spiegel, Susan Edelstein, Yang Yang
Nephrology Nursing Journal. 2025-07-07
9 citations
Tenapanor as Therapy for Hyperphosphatemia in Maintenance Dialysis Patients: Results from the OPTIMIZE Study.
Stuart M Sprague, Daniel E Weiner, David P Tietjen, Pablo E Pergola, Steven Fishbane
Kidney360. 2024-05-01

Press Mentions

Meet Me at the MeetingSeptember 19th, 2022
Expert COVID-19 Content on Open Access as Delta SurgesSeptember 7th, 2021
Kidney Advocates Earn President's Service Awards for COVID-19 EffortsNovember 9th, 2020